Zdrowie i gospodarka · 31/10/2006

FDA Requests Public Comment on Proposed Collection of Biological Product Deviation Reporting Information

The Food and Drug Administration (FDA) is seeking public input on its proposed collection of information related to reporting biological product deviations in manufacturing, as required by the Paperwork Reduction Act of 1995, and invites comments on the proposed use of Forms FDA 3486 and 3486A.